CD34 and diabetes mellitus: Our focus on PAI-1 arose from the observation that diabetic individuals protected from vascular complications despite less than optimal diabetes control showed lower PAI-1 transcript levels in their CD34+ cells, and these same individuals expressed higher levels of uPA.